RespiQ Information

At RespiQ, we are transforming health monitoring by bringing the analytical precision of a clinical lab directly into patients' homes, measuring biomarkers in their breath. Powered by our proprietary cold-plasma optical spectroscopy and explainable AI (XAI), our compact device captures real-time, non-invasive biomarker intelligence from a single breath at parts-per-billion (ppb) sensitivity. Today, we empower biopharma and clinical nutrition sponsors to eliminate critical trial data blind spots—replacing subjective symptom diaries with continuous, lab-grade molecular data to de-risk drug development and accelerate clinical timelines. Tomorrow, our vision reaches far beyond the trial site: we are pioneering proactive at-home monitoring for high-burden chronic diseases, starting with early lung attack detection in COPD and expanding across gastrointestinal (GI) and systemic care. By shifting healthcare from reactive crisis management to timely, personalized intervention, RespiQ is unlocking continuous breathomics to make remote care smarter, earlier, and patient-centric.